NCT07108036Phase 2Recruiting

A Study to Assess Anktiva in Patients With Long Covid-19.

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2026-10Estimated

Enrollment · participants20Estimated

Source updated2026-05-11Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-03-27 · 1 field changed

Recruitment status changed

− Before

~~Not yet recruiting~~

+ After

Recruiting

Check registry source

Posted 2025-10-20 · 1 field changed

Primary completion date changed

− Before

~~Aug 2026~~

+ After

Oct 2026

Check registry source

Study details

Conditions studied

Long COVID

Treatments or interventions studied

N-803 (IL-15 Superagonist)Drug

Primary outcomes · main study measures

Read the study measures

measure: Incidence of treatment emergent adverse events (TEAEs) through 30 days post final study drug administration.; timeFrame: Through 30 days post final study drug administration.; measure: Incidence of grade 3 or higher TEAEs through 30 days post final study drug administration.; timeFrame: Through 30 days post final study drug administration.; measure: Incidence of serious adverse events (SAEs) through 30 days post final study drug administration.; timeFrame: Through 30 days post final study drug administration.; measure: Incidence of abnormal changes in safety laboratory tests (CBC and CMP).; timeFrame: Through the end of the study treatment period (approximately 75 days); measure: Clinically important changes in vital signs.; timeFrame: Through the end of the study treatment period (approximately 75 days)

History coverage

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

How to read this history